Codiak BioSciences
Cash Flow

Last updated:

Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Codiak BioSciences generated cash of -$74,144,000, which is less than the previous year. Cash used in financing activities reached the amount of $65,412,000 last year. Net change in cash is therefore -$11,977,000.

Cash Flow

Codiak BioSciences, Inc. (NASDAQ:CDAK): Cash Flow
2018 -30.57M -78.54M -58K
2019 -1.70M -11.66M 9.76M
2020 -63.36M 52.01M 89.58M
2021 -74.14M -3.24M 65.41M

CDAK Cash Flow Statement (2018 – 2021)

2021 2020 2019 2018
Cash at beginning of period
93.08M14.85M18.46M127.63M
Operating activities
Net income
-37.15M-91.66M-77.96M-44.54M
Adjustments to reconcile net income to cash generated by operating activities:
Depreciation and amortization
6.42M5.54M2.77M1.72M
Stock-based compensation expense
10.14M7.08M7.24M5.36M
Deferred income tax benefit 10.14M7.08M7.24M5.36M
Changes in operating assets and liabilities:
Accounts receivable, net
0000
Inventories
0000
Accounts payable
96K-378K1.46M-536K
Cash generated by operating activities
-74.14M-63.36M-1.70M-30.57M
Investing activities
Purchases Of Investments
00-130.69M-97.22M
Investments In Property Plant And Equipment
-3.24M-21.05M-10.47M-8.31M
Acquisitions Net
0006.5M
Cash generated by investing activities
-3.24M52.01M-11.66M-78.54M
Financing activities
Common Stock Issued
61.67M74.35M259K43K
Payments for dividends
0000
Repurchases of common stock
0000
Repayments of term debt
0000
Cash used in financing activities
65.41M89.58M9.76M-58K
Net Change In Cash
-11.97M78.23M-3.60M-109.17M
Cash at end of period
81.10M93.08M14.85M18.46M
Data sourceData source